SOURCE: Gene Express, Inc.

March 30, 2006 11:28 ET

Gene Express Retains The Global Consulting Group as Investor Relations and Public Relations Counsel

TOLEDO, OH -- (MARKET WIRE) -- March 30, 2006 -- Gene Express, Inc. today announced that it has retained The Global Consulting Group as the Company's strategic investor relations and public relations counsel.

Gerald Vardzel, CEO of Gene Express, said, "We selected The Global Consulting Group based on its reputation and proven track record of adding value and developing relationships with the investment community and media. Their extensive healthcare experience will be invaluable as we move forward with our plan to access the capital markets and execute our strategy. We are committed to maintaining an open and proactive dialogue with the market."

Anne S. McBride, Vice Chair of Investor Relations and Financial Communications for The Global Consulting Group, commented, "We are excited to work with Gene Express to increase the company's exposure to key constituents within the financial community and the healthcare sector. We look forward to implementing a strategic communications program that effectively communicates the Company's business strategy and growth opportunities."

About Gene Express, Inc.

Gene Express, Inc. accelerates and enables drug development by providing standardized genomic data. The Company's proprietary and patented StaRT-PCR™ (Standardized Reverse Transcriptase Polymerase Chain Reaction) platform technology for measuring gene expression levels in cells, tissue and blood is being used by numerous pharmaceutical concerns, as well as leading academic centers. The Company's $3 billion focus market for licensing and contract services includes the drug development, academic and molecular diagnostics segments. Additional information is available on the Company's website at www.geneexpressinc.com.

Any forecasts, plans, projections and other information contained in this press release describing events or results that may occur in the future are "forward-looking statements" as defined in the United States Private Securities litigation Reform Act of 1995. Forward-looking statements are subject to risks, uncertainties and important factors that are beyond the control of the Company that could cause actual results and events to differ materially from the results presently anticipated or projected. Readers are cautioned not to place undue reliance on these forward-looking statements and any such forward-looking statements are qualified in their entirety by reference to this cautionary statement. All forward-looking statements contained herein speak only as of the date of this release and are based on current expectations. The Company disclaims any obligation to update or revise any forward-looking statements.

Contact Information

  • Contact:
    Rachel Levine
    The Global Consulting Group
    Tel: 646-284-9439
    E: Email Contact